Panmigran (Paracetamol, Acetylsalicylic Acid, Caffeine)

Paracetamol reduces pain and fever by centrally inhibiting COX enzymes. Aspirin irreversibly blocks peripheral COX‑1 and COX‑2, decreasing inflammation and platelet aggregation. Caffeine antagonises adenosine receptors, stimulating the central nervous system and enhancing the analgesic effect of the other two ingredients, resulting in faster and stronger symptom relief.

The appropriate dose of Panmigran is determined by the prescribing healthcare professional based on the patient’s condition, age, weight and clinical response. Patients should follow the prescriber’s instructions and not exceed the recommended amount.

Panmigran should be used with caution during pregnancy, especially in the third trimester, because aspirin can affect fetal circulation. Breastfeeding mothers should consult a physician, as the components may pass into milk. The prescriber will weigh benefits against potential risks.

To order Panmigran, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with single‑ingredient products such as paracetamol alone, Panmigran adds aspirin for anti‑inflammatory action and caffeine for enhanced analgesia, often providing faster and more complete pain relief. However, it also carries the combined safety profile of all three ingredients, requiring attention to bleeding risk and caffeine‑related effects.

Panmigran tablets should be stored at ambient temperature, below 25 °C, in their original packaging to protect from moisture and light. Keep out of reach of children and do not use after the expiry date printed on the label.

Panmigran is taken orally, usually with a full glass of water. It can be taken with or without food, but patients with sensitive stomachs may prefer to take it with meals to minimise gastric irritation.

Serious risks include gastrointestinal bleeding, especially in patients taking other anticoagulants or NSAIDs, severe allergic reactions such as anaphylaxis, and liver toxicity from excessive paracetamol exposure. Patients should seek immediate medical attention if they notice signs of bleeding, rash, or jaundice.

Panmigran is contraindicated in individuals with known hypersensitivity to paracetamol, aspirin or caffeine, those with active peptic ulcer disease, severe liver or kidney impairment, and in children with viral infections due to the risk of Reye syndrome. Pregnant women in the third trimester should also avoid it unless advised by a physician.